Date: 2011-05-10
Type of information:
Compound: new technologies for the standardisation of the manufacture of stem cells for their use in cell therapy and drug development screening
Company: Sistemic Ltd (UK) Roslin Cells Ltd (UK)
Therapeutic area:
Type agreement: Collaboration Promotion
Action mechanism: Cell therapy
Disease:
Details: Sistemic Ltd and Roslin Cells Ltd have signed a Memorandum of Understanding to promote the development of new technologies for the standardisation of the manufacture of stem cells for their use in cell therapy and drug development screening. Both parties believe that only through the development of stem cell standardisation can the full potential of this major opportunity be unlocked.
Financial terms:
Latest news:
